BRIEF published on 12/05/2025 at 18:39, 3 months 12 days ago Valneva Updates Share and Voting Rights as of November 2025 Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
PRESS RELEASE published on 12/05/2025 at 18:34, 3 months 12 days ago VALNEVA Declaration of shares and voting rights: November 30, 2025 VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF published on 12/03/2025 at 11:03, 3 months 14 days ago Valneva SE: Promising Developments in Lyme Disease Vaccine Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
PRESS RELEASE published on 12/03/2025 at 10:58, 3 months 14 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF published on 11/04/2025 at 07:05, 4 months 13 days ago Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
PRESS RELEASE published on 11/04/2025 at 07:00, 4 months 13 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF published on 10/09/2025 at 16:04, 5 months 8 days ago Bpifrance Crosses Threshold in the Capital of Valneva SE Stock Market Valneva SE Threshold Crossing Bpifrance Deposit Fund
BRIEF published on 10/06/2025 at 07:35, 5 months 11 days ago Valneva Updates on Shares and Voting Rights Voting Rights Shares Euronext Valneva France
PRESS RELEASE published on 10/06/2025 at 07:30, 5 months 11 days ago VALNEVA Declaration of shares and voting rights: September 30, 2025 Valneva declares transfer into bearer form of 653 shares with double voting rights and grants double voting rights on 100 ordinary shares, affecting total voting rights Voting Rights Valneva Shares Transfer Double Rights Bearer Form
BRIEF published on 09/03/2025 at 07:05, 6 months 14 days ago Valneva's Lyme Disease Vaccine Makes Significant Progress Valneva Safety Phase 2 Lyme Vaccine Immunogenicity
Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 6 hours 17 minutes ago Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho
Published on 03/17/2026 at 17:58, 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 15:30, 3 hours 17 minutes ago Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy
Published on 03/17/2026 at 15:19, 3 hours 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 03/17/2026 at 07:00, 11 hours 47 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:56, 1 day ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
